Home Applications 208261 Application 208261
Type NDA
Sponsor MERCK SHARP DOHME Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZEPATIER ELBASVIR; GRAZOPREVIR TABLET;ORAL 50MG;100MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208261-001 ZEPATIER ELBASVIR; GRAZOPREVIR 50MG;100MG TABLET / ORAL RLD 2016-01-28
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD 2016-01-28 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD 2016-01-28 c2088c7a36db…2026-09-14 22:38:34 2026-08 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD 2016-01-28 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD 2016-01-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD 2016-01-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208261-001 ZEPATIER 50MG;100MG TABLET / ORAL RLD, RS 2016-01-28 3bdfa0b2c4d7…
Observed Orange Book patent history# Patent history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 e64feba35796…2022-09-29 23:25 UTC 2022-09 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N208261-001 7973040 2029-07-24 U-1813 Drug substance, Drug product 2016-02-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N208261-001 8871759 2031-05-04 U-1813 Drug substance, Drug product 2016-02-25 a50c72e98297…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZEPATIER ELBASVIR AND GRAZOPREVIR Merck Sharp & Dohme LLC 164dc02a-9180-426a-b8b5-04ab39d2bbd4 2026-03-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 208261 application number: NDA208261 ndc (product): 0006-3074
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme LLC NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current 0006-3074 ZEPATIER elbasvir and grazoprevir Merck Sharp & Dohme Corp. NDA Current